Abstract:Chaperonins are biological nanomachines that help newly translated proteins to fold by rescuing them from kinetically trapped misfolded states. Protein folding assistance by the chaperonin machinery is obligatory in vivo for a subset of proteins in the bacterial proteome. Chaperonins are large oligomeric complexes, with unusual seven fold symmetry (group I) or eight/nine fold symmetry (group II), that form double-ring constructs, enclosing a central cavity that serves as the folding chamber. Dramatic large-scale conformational changes, that take place during ATP-driven cycles, allow chaperonins to bind misfolded proteins, encapsulate them into the expanded cavity and release them back into the cellular environment, regardless of whether they are folded or not. The theory associated with the iterative annealing mechanism, which incorporated the conformational free energy landscape description of protein folding, quantitatively explains most, if not all, the available data. Misfolded conformations are associated with low energy minima in a rugged energy landscape. Random disruptions of these low energy conformations result in higher free energy, less folded, conformations that can stochastically partition into the native state. Two distinct mechanisms of annealing action have been described. Group I chaperonins (GroEL homologues in eubacteria and endosymbiotic organelles), recognize a large number of misfolded proteins non-specifically and operate through highly coordinated cooperative motions. By contrast, the less well understood group II chaperonins (CCT in Eukarya and thermosome/TF55 in Archaea), assist a selected set of substrate proteins. Sequential conformational changes within a CCT ring are observed, perhaps promoting domain-by-domain substrate folding. Chaperonins are implicated in bacterial infection, autoimmune disease, as well as protein aggregation and degradation diseases. Understanding the chaperonin mechanism and the specific proteins they rescue during the cell cycle is important not only for the fundamental aspect of protein folding in the cellular environment, but also for effective therapeutic strategies.

The unhappy chaperone

Mechanistic Insights into the Role of Molecular Chaperones in Protein Misfolding Diseases: From Molecular Recognition to Amyloid Disassembly

Molecular mechanisms used by chaperones to reduce the toxicity of aberrant protein oligomers

Chaperoning Proteins for Destruction: Diverse Roles of Hsp70 Chaperones and their Co-Chaperones in Targeting Misfolded Proteins to the Proteasome

Increased surface charge in the protein chaperone Spy enhances its anti-aggregation activity

Modulation of Amyloid States by Molecular Chaperones

Effect of molecular chaperones on aberrant protein oligomers in vitro: super-versus sub-stoichiometric chaperone concentrations

Molecular Chaperones: A Double-Edged Sword in Neurodegenerative Diseases

Friends in need: How chaperonins recognize and remodel proteins that require folding assistance

Chaperone machines for protein folding, unfolding and disaggregation

Chaperone quality control in liquid-phase separated organelles

Chaperones in control of protein disaggregation

Kinetic analysis reveals the diversity of microscopic mechanisms through which molecular chaperones suppress amyloid formation

Molecular chaperones and their denaturing effect on client proteins

Molecular Chaperones in Cellular Protein Folding: Mechanisms and Pathways

Molecular chaperones are nanomachines that catalytically unfold misfolded and alternatively folded proteins

The therapeutic potential of chemical chaperones in protein folding diseases

Thermodynamic Stability Modulates Chaperone-Mediated Disaggregation of α-Synuclein Fibrils

Protein Aggregation: Opposing Effects of Chaperones and Crowding

Molecular chaperones in protein folding and proteostasis